IHS Chemical Week

Chemical Week Magazine :: New Construction Projects

GSK Builds Biopharmaceutical Manufacturing Facility in the U.K.

5:57 AM MDT | April 6, 2012

GlaxoSmithKline (GSK) has confirmed plans, originally outlined in 2010, to invest more than £500 million ($799 million) in R&D and manufacturing in the U.K. GSK will invest £350 million of the total to build a biopharmaceutical manufacturing facility at the company’s Ulverston site. It will be the first new manufacturing plant to be built by GSK in the U.K. for 40 years. The company will also spend £100 million of the total at its existing manufacturing operations at Montrose and Irvine. GSK will invest the remaining £50 million in early-stage...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa